December 30th 2025, 2:00pm
By Alex Biese
CURE spoke with an expert about smoking-related stigmas often faced by patients with lung cancer.
December 29th 2025, 4:00pm
By Dr. Ariel Ostad
Dr. Ariel Ostad sat down to discuss the often-overlooked emotional and practical challenges that patients face during and after skin cancer treatment.
December 29th 2025, 7:00pm
By Kyle Doherty
Piqray plus Faslodex improved progression-free survival versus Faslodex alone in CDK4/6 inhibitor–pretreated, PIK3CA-mutated advanced breast cancer.
December 29th 2025, 2:00pm
By Gina Mauro
Dr. Roshani Patel answers questions from patients with breast cancer on Keytruda-induced colitis, sugar intake during chemo, and how to stay active.
December 28th 2025, 7:00pm
By Joe McDonough
Joe McDonough sat down for an interview with CURE to share his family’s story and the inspiration behind the B+ Foundation.
December 28th 2025, 3:00pm
By Mayra Andujar-Delgado
Mayra Andujar-Delgado shares how Dr. Faseeh Khaja’s compassionate care and unique bedside manner earned him recognition at the 2025 Blood Cancer Heroes.
December 27th 2025, 3:00pm
By Oya Gilbert
Oya Gilbert, diagnosed with multiple myeloma in 2017, advises patients to bring someone to appointments, ask questions and seek second opinions.
December 27th 2025, 7:00pm
By Bill Potts
Cancer survivor and author Bill Potts was recently honored as a Blood Cancer Hero.
December 26th 2025, 4:00pm
By Courtney Flaherty
Orserdu plus Verzenio or Afinitor was well tolerated and showed early signs of effectiveness in advanced ER-positive, HER2-negative breast cancer.
December 26th 2025, 2:00pm
By Patricia I. Moreno
CURE spoke with an expert about why a support system is crucial for patients with lung cancer.
December 25th 2025, 4:00pm
BOOG 13-08 shows skipping sentinel lymph node biopsy in patients 50+ with early-stage, hormone receptor–positive, HER2-negative breast cancer is safe.
December 25th 2025, 2:00pm
Learn how diet and exercise impact breast cancer risk, while getting authoritative guidelines on plate balance, fiber goals, and complex vs. simple carbs.
December 24th 2025, 10:00pm
By Spencer Feldman
CURE was on site at the 2025 ASH Annual Meeting, sharing expert conversations and patient-focused reporting that highlighted progress in blood cancer care.
December 24th 2025, 8:00pm
By Laura Yeager
All I can say is thank you Healthwell Foundation for giving our brother life, and for giving our whole family unit life. Because of you, we can keep on keeping on.
December 24th 2025, 4:00pm
Ceralasertib plus Imfinzi failed to improve overall survival versus docetaxel in a phase 3 study of previously treated non-small cell lung cancer.
Reading the Fine Print: Why Ingredient Awareness Matters After Cancer
Stigmas Faced by Patients With Lung Cancer
Understanding the Emotional Challenges of Skin Cancer Treatment
Piqray Plus Faslodex Improves PFS in Advanced Breast Cancer